Korro to Participate in Upcoming Investor Conferences
Korro Bio, Inc. (KRRO)
Company Research
Source: GlobeNewswire
CAMBRIDGE, Mass., April 01, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that Chief Executive Officer and President, Ram Aiyar, Ph.D., Chief Financial Officer, Vineet Agarwal, and Chief Scientific Officer, Steve Colletti, Ph.D., will participate, present, and meet investors regarding progress of KRRO-110, Korro’s best-in-class candidate for AATD, at the following upcoming investor conferences: 23rd Annual Needham Healthcare ConferenceFormat: PresentationDate and Time: Monday, April 8, 2024, 1:30 p.m. ET Piper Sandler Spring Biopharma Symposium Date: Tuesday, April 16, 2024 Citizens JMP Life Sciences ConferenceFormat: PresentationDate and Time: Monday, May 13, 2024, 12:30 p.m. ET 2024 RBC Capital Markets Global Healthcare Conference Format: PresentationDate and Time: Tuesday, May 14, 2024, 10:00 a.m. ET Bank of America Securities Health Care Conference 2024Format: PresentationDate and Time: Wednesday, May 15, 2024, 11:15 a.m. ET The live webca
Show less
Read more
Impact Snapshot
Event Time:
KRRO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KRRO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KRRO alerts
High impacting Korro Bio, Inc. news events
Weekly update
A roundup of the hottest topics
KRRO
News
- Otolith Labs Rounds Out Executive Team with Appointment of Kevin Franck, PhD, MBA as Chief Clinical Officer [Yahoo! Finance]Yahoo! Finance
- Korro Announces $70 Million Private PlacementGlobeNewswire
- Korro Bio, Inc. (NASDAQ: KRRO) had its price target raised by analysts at HC Wainwright from $100.00 to $115.00. They now have a "buy" rating on the stock.MarketBeat
- Korro Bio, Inc. (NASDAQ: KRRO) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $180.00 price target on the stock.MarketBeat
- Korro Bio, Inc. (NASDAQ: KRRO) had its price target raised by analysts at Royal Bank of Canada from $70.00 to $90.00. They now have an "outperform" rating on the stock.MarketBeat
KRRO
Sec Filings
- 5/1/24 - Form DEFA14A
- 4/29/24 - Form ARS
- 4/29/24 - Form DEFA14A
- KRRO's page on the SEC website